DK3756667T3 - Inhibitorer af adamts4 eller adamts5 til anvendelse i forebyggelse eller behandling af kardiel remodellering og kronisk hjertesvigt - Google Patents
Inhibitorer af adamts4 eller adamts5 til anvendelse i forebyggelse eller behandling af kardiel remodellering og kronisk hjertesvigt Download PDFInfo
- Publication number
- DK3756667T3 DK3756667T3 DK20188474.9T DK20188474T DK3756667T3 DK 3756667 T3 DK3756667 T3 DK 3756667T3 DK 20188474 T DK20188474 T DK 20188474T DK 3756667 T3 DK3756667 T3 DK 3756667T3
- Authority
- DK
- Denmark
- Prior art keywords
- adamts4
- adamts5
- inhibitors
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1312311.2A GB201312311D0 (en) | 2013-07-09 | 2013-07-09 | Uses of enzyme inhibitors |
| EP14736417.8A EP3019178B1 (en) | 2013-07-09 | 2014-07-09 | Inhibitors of adamts4 or adamts5 for use in preventing or treating cardiac remodeling and chronic heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3756667T3 true DK3756667T3 (da) | 2023-03-27 |
Family
ID=49033561
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20188474.9T DK3756667T3 (da) | 2013-07-09 | 2014-07-09 | Inhibitorer af adamts4 eller adamts5 til anvendelse i forebyggelse eller behandling af kardiel remodellering og kronisk hjertesvigt |
| DK14736417.8T DK3019178T3 (da) | 2013-07-09 | 2014-07-09 | Inhibitorer af adamts4 eller adamts5 til anvendelse i forebyggelse af eller behandling af kardiel remodellering og kronisk hjertesvigt |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14736417.8T DK3019178T3 (da) | 2013-07-09 | 2014-07-09 | Inhibitorer af adamts4 eller adamts5 til anvendelse i forebyggelse af eller behandling af kardiel remodellering og kronisk hjertesvigt |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10322143B2 (da) |
| EP (2) | EP3019178B1 (da) |
| DK (2) | DK3756667T3 (da) |
| ES (2) | ES2940790T3 (da) |
| FI (1) | FI3756667T3 (da) |
| GB (1) | GB201312311D0 (da) |
| PT (2) | PT3756667T (da) |
| WO (1) | WO2015004209A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023070164A1 (en) * | 2021-10-28 | 2023-05-04 | Paradigm Biopharmaceuticals Ltd | Treatment of heart failure with preserved ejection fraction |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA99001974A (es) * | 1996-12-09 | 2002-03-27 | Warner Lambert Co | Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular. |
| AU2003207795B2 (en) * | 2002-01-31 | 2009-01-08 | Wyeth | Aggrecanase molecules |
| JP2007525406A (ja) * | 2003-12-04 | 2007-09-06 | ワイス | ビアリールスルホンアミドおよびその使用方法 |
| US20070155737A1 (en) * | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| KR20080031379A (ko) | 2005-07-11 | 2008-04-08 | 와이어쓰 | 글루타메이트 아그레카나제 저해제 |
| WO2007016482A2 (en) * | 2005-07-29 | 2007-02-08 | Imperial Innovations Limited | Mutant timp-3 |
| US8871741B2 (en) * | 2010-01-15 | 2014-10-28 | Icahn School Of Medicine At Mount Sinai | Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate |
-
2013
- 2013-07-09 GB GBGB1312311.2A patent/GB201312311D0/en not_active Ceased
-
2014
- 2014-07-09 ES ES20188474T patent/ES2940790T3/es active Active
- 2014-07-09 WO PCT/EP2014/064761 patent/WO2015004209A1/en active Application Filing
- 2014-07-09 DK DK20188474.9T patent/DK3756667T3/da active
- 2014-07-09 DK DK14736417.8T patent/DK3019178T3/da active
- 2014-07-09 PT PT201884749T patent/PT3756667T/pt unknown
- 2014-07-09 EP EP14736417.8A patent/EP3019178B1/en active Active
- 2014-07-09 US US14/903,624 patent/US10322143B2/en active Active
- 2014-07-09 FI FIEP20188474.9T patent/FI3756667T3/fi active
- 2014-07-09 EP EP20188474.9A patent/EP3756667B1/en active Active
- 2014-07-09 ES ES14736417T patent/ES2854924T3/es active Active
- 2014-07-09 PT PT147364178T patent/PT3019178T/pt unknown
-
2019
- 2019-05-06 US US16/403,882 patent/US10744155B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10744155B2 (en) | 2020-08-18 |
| GB201312311D0 (en) | 2013-08-21 |
| WO2015004209A1 (en) | 2015-01-15 |
| ES2940790T3 (es) | 2023-05-11 |
| EP3019178A1 (en) | 2016-05-18 |
| EP3019178B1 (en) | 2020-12-09 |
| EP3756667B1 (en) | 2023-01-25 |
| US20190282606A1 (en) | 2019-09-19 |
| PT3756667T (pt) | 2023-03-30 |
| PT3019178T (pt) | 2021-03-01 |
| ES2854924T3 (es) | 2021-09-23 |
| DK3019178T3 (da) | 2021-03-01 |
| EP3756667A1 (en) | 2020-12-30 |
| US10322143B2 (en) | 2019-06-18 |
| US20160158271A1 (en) | 2016-06-09 |
| FI3756667T3 (fi) | 2023-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3693158T3 (da) | Asymmetrisk forarbejdningsfremgangsmåde til krumningsreduktion i laminatstrukturer | |
| DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
| DK3212208T3 (da) | Anvendelse af l. reuteri til forebyggelse eller behandling af mikrobiotadysbiose tidligt i livet | |
| DK3149019T3 (da) | Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme | |
| DK2964327T3 (da) | Anordninger og fremgangsmåder til multifokal ultralydsterapi | |
| DK3395353T3 (da) | Plasminogen til anvendelse til behandling eller forebyggelse af diabetes-mellitus-nerveskade | |
| KR102068915B9 (ko) | 조직 인자 경로 억제제 항체 및 그의 용도 | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK2950764T3 (da) | Sårhage/stabilisator til overskydende og/eller overflødigt væv | |
| DK3204497T3 (da) | Terapeutisk hæmning af lactatdehydrogenase og midler dertil | |
| DK2958926T3 (da) | Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf | |
| DK3087648T3 (da) | Systemer og metoder til belastningsharmonisk undertrykkelse | |
| DK3366307T3 (da) | Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri | |
| DK3268374T3 (da) | Kv1.3-inhibitorer og deres medicinske anvendelse | |
| DK3022361T4 (da) | Rambuk og fremgangsmåde til anvendelse deraf | |
| DK2702992T3 (da) | Anvendelse af melatonin til behandling af og/eller forebyggelse af mucositis | |
| DK2984184T3 (da) | Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer | |
| HK1222794A1 (zh) | 預防或治療左心室重塑的方法 | |
| DK3240821T3 (da) | Lavdosis gashydrathæmmersammensætning og tilhørende fremgangsmåde | |
| DK3463436T3 (da) | Vaccine i kombination med en immuncheckpoint-hæmmer til anvendelse i cancerbehandling | |
| DK3093022T3 (da) | Gata-3-inhibitorer til anvendelse i behandlingen af th2-drevet astma | |
| DK2827883T3 (da) | Tfpi-inhibitorer og fremgangsmåder til anvendelse | |
| DK3027016T3 (da) | Opløsninger til øget stabilitet og holdbarhed for en organvævskonserveringsopløsning | |
| DK3277682T3 (da) | 6-morpholinyl-2-pyrazolyl-9h-purinderivater og anvendelse heraf som pi3k- hæmmere | |
| DK3373922T3 (da) | Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri |